Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-05

Clinical Trial Update: Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating combining clopidogrel with atorvastatin or rosuvastatin in patients with large-vessel ischemic stroke; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CRESTOR (Rosuvastatin)
  • Lipitor (atorvastatin)
  • Plavix (clopidogrel)

Snippet

Sponsor: Kafrelsheikh University | Conditions: Ischemic Stroke | Phase 3 | Status: RECRUITING